home
docs

Yemen Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV) 2026: Interactive Chart & Historical Data

Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV) in Yemen stood at 11% in 2024, according to World Bank. The latest value is down 2 percentage points from 13% in 2023. Ten years earlier, in 2014, the value was 5% (up 6 percentage points since). The highest value since 2000 was 14% in 2022, the lowest 0% in 2000. Yemen ranked 76th highest of the 77 countries in this dataset in 2024; Botswana ranked first.

Data source: World Bank · Unit: % · Category: Healthcare · Explore more indicators on EconDash

Data updated:Last checked:Frequency:AnnualCoverage:2000–2024

Key facts

What is the latest Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV) in Yemen?

Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV) in Yemen stood at 11% in 2024, according to World Bank.

Is Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV) in Yemen rising or falling?

The latest value is down 2 percentage points from 13% in 2023. Ten years earlier, in 2014, the value was 5% (up 6 percentage points since).

How does Yemen rank for Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)?

Yemen ranked 76th highest of the 77 countries in this dataset in 2024; Botswana ranked first.

What is the highest Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV) on record in Yemen?

The highest value since 2000 was 14% in 2022, the lowest 0% in 2000.

Metadata for Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV) in Yemen
IndicatorAntiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)
CountryYemen
CategoryHealthcare
Unit%
SourceWorld Bank
Interactive chartView on EconDash
API accessEconDash API documentation

Latest value: 11% (2024)

Loading chart...

Cite this chart
APA

World Bank. (2026). Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV) — Yemen [Data set]. Retrieved November 13, 2026, from EconDash: https://econdash.org/chart/wdi-sh-hiv-pmtc-zs/YEM. Original source: https://data.worldbank.org/indicator/SH.HIV.PMTC.ZS

MLA

World Bank. "Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV) — Yemen." EconDash, 2026, https://econdash.org/chart/wdi-sh-hiv-pmtc-zs/YEM. Accessed 13 Nov. 2026. Original source: https://data.worldbank.org/indicator/SH.HIV.PMTC.ZS.

Chicago

World Bank. 2026. "Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV) — Yemen." EconDash. Accessed November 13, 2026. https://econdash.org/chart/wdi-sh-hiv-pmtc-zs/YEM. Original source: https://data.worldbank.org/indicator/SH.HIV.PMTC.ZS.

BibTeX
@misc{econdash_wdi_sh_hiv_pmtc_zs_yem,
  author = {{World Bank}},
  title = {{Antiretroviral therapy coverage for PMTCT (\% of pregnant women living with HIV) --- Yemen}},
  howpublished = {EconDash},
  year = {2026},
  url = {https://econdash.org/chart/wdi-sh-hiv-pmtc-zs/YEM},
  note = {Accessed: 2026-11-13. Original source: https://data.worldbank.org/indicator/SH.HIV.PMTC.ZS}
}